학술논문
Application of full-genome analysis to diagnose rare monogenic disorders.
Document Type
article
Author
Shieh, Joseph T; Penon-Portmann, Monica; Wong, Karen HY; Levy-Sakin, Michal; Verghese, Michelle; Slavotinek, Anne; Gallagher, Renata C; Mendelsohn, Bryce A; Tenney, Jessica; Beleford, Daniah; Perry, Hazel; Chow, Stephen K; Sharo, Andrew G; Brenner, Steven E; Qi, Zhongxia; Yu, Jingwei; Klein, Ophir D; Martin, David; Kwok, Pui-Yan; Boffelli, Dario
Source
NPJ genomic medicine. 6(1)
Subject
Language
Abstract
Current genetic testenhancer and narrows the diagnostic intervals for rare diseases provide a diagnosis in only a modest proportion of cases. The Full-Genome Analysis method, FGA, combines long-range assembly and whole-genome sequencing to detect small variants, structural variants with breakpoint resolution, and phasing. We built a variant prioritization pipeline and tested FGA's utility for diagnosis of rare diseases in a clinical setting. FGA identified structural variants and small variants with an overall diagnostic yield of 40% (20 of 50 cases) and 35% in exome-negative cases (8 of 23 cases), 4 of these were structural variants. FGA detected and mapped structural variants that are missed by short reads, including non-coding duplication, and phased variants across long distances of more than 180 kb. With the prioritization algorithm, longer DNA technologies could replace multiple tests for monogenic disorders and expand the range of variants detected. Our study suggests that genomes produced from technologies like FGA can improve variant detection and provide higher resolution genome maps for future application.